Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation
Conditions
Interventions
- OTHER: Oliclinomel N4
- OTHER: Compounded ternary parenteral nutrition admixtures
Sponsor
Baxter Healthcare Corporation